160 related articles for article (PubMed ID: 35968487)
21. Cervical cancer screening among young adult women in the United States.
Roland KB; Benard VB; Soman A; Breen N; Kepka D; Saraiya M
Cancer Epidemiol Biomarkers Prev; 2013 Apr; 22(4):580-8. PubMed ID: 23355601
[TBL] [Abstract][Full Text] [Related]
22. Acceptability and Feasibility of HPV Self-Sampling as an Alternative Primary Cervical Cancer Screening in Under-Screened Population Groups: A Cross-Sectional Study.
Wong EL; Cheung AW; Wong AY; Chan PK
Int J Environ Res Public Health; 2020 Aug; 17(17):. PubMed ID: 32867315
[No Abstract] [Full Text] [Related]
23. Comparison of cervical cancer screening results among 256,648 women in multiple clinical practices.
Blatt AJ; Kennedy R; Luff RD; Austin RM; Rabin DS
Cancer Cytopathol; 2015 May; 123(5):282-8. PubMed ID: 25864682
[TBL] [Abstract][Full Text] [Related]
24. Trends Over Time in Pap and Pap-HPV Cotesting for Cervical Cancer Screening.
MacLaughlin KL; Jacobson RM; Radecki Breitkopf C; Wilson PM; Jacobson DJ; Fan C; St Sauver JL; Rutten LJF
J Womens Health (Larchmt); 2019 Feb; 28(2):244-249. PubMed ID: 30614380
[TBL] [Abstract][Full Text] [Related]
25. Cervical Cancer Screening Preferences Among Trans-Masculine Individuals: Patient-Collected Human Papillomavirus Vaginal Swabs Versus Provider-Administered Pap Tests.
McDowell M; Pardee DJ; Peitzmeier S; Reisner SL; Agénor M; Alizaga N; Bernstein I; Potter J
LGBT Health; 2017 Aug; 4(4):252-259. PubMed ID: 28665783
[TBL] [Abstract][Full Text] [Related]
26. Factors associated with human papillomavirus (HPV) test acceptability in primary screening for cervical cancer: A mixed methods research synthesis.
Tatar O; Thompson E; Naz A; Perez S; Shapiro GK; Wade K; Zimet G; Gilca V; Janda M; Kahn J; Daley E; Rosberger Z
Prev Med; 2018 Nov; 116():40-50. PubMed ID: 30172799
[TBL] [Abstract][Full Text] [Related]
27. Acceptability and feasibility of a community based participatory research project comparing cytology and urine HPV DNA testing for cervical cancer screening in Yap, Federated States of Micronesia.
Sy AU; Hernandez BY; Tareg A; Reichhardt M; Buenconsejo-Lum L
Cancer Epidemiol; 2017 Oct; 50(Pt B):283-288. PubMed ID: 29120838
[TBL] [Abstract][Full Text] [Related]
28. Protecting the underscreened women in developed countries: the value of HPV test.
Ibáñez R; Autonell J; Sardà M; Crespo N; Pique P; Pascual A; Martí C; Fibla M; Gutiérrez C; Lloveras B; Moreno-Crespi J; Torrent A; Baixeras N; Alejo M; Bosch FX; de Sanjosé S
BMC Cancer; 2014 Aug; 14():574. PubMed ID: 25102758
[TBL] [Abstract][Full Text] [Related]
29. Women's intentions to receive cervical cancer screening with primary human papillomavirus testing.
Ogilvie GS; Smith LW; van Niekerk DJ; Khurshed F; Krajden M; Saraiya M; Goel V; Rimer BK; Greene SB; Hobbs S; Coldman AJ; Franco EL
Int J Cancer; 2013 Dec; 133(12):2934-43. PubMed ID: 23754203
[TBL] [Abstract][Full Text] [Related]
30. Screening for Cervical Cancer.
Eun TJ; Perkins RB
Med Clin North Am; 2020 Nov; 104(6):1063-1078. PubMed ID: 33099451
[TBL] [Abstract][Full Text] [Related]
31. Recent changes in cervical cancer screening guidelines: U.S. women's willingness for HPV testing instead of Pap testing.
Thompson EL; Galvin AM; Daley EM; Tatar O; Zimet GD; Rosberger Z
Prev Med; 2020 Jan; 130():105928. PubMed ID: 31756351
[TBL] [Abstract][Full Text] [Related]
32. Does the primary screening test influence women's anxiety and intention to screen for cervical cancer? A randomized survey of Norwegian women.
Burger EA; Nygård M; Gyrd-Hansen D; Moger TA; Kristiansen IS
BMC Public Health; 2014 Apr; 14():360. PubMed ID: 24735469
[TBL] [Abstract][Full Text] [Related]
33. Glandular Lesions of the Cervix in Clinical Practice: A Cytology, Histology, and Human Papillomavirus Correlation Study From 2 Institutions.
Miller RA; Mody DR; Tams KC; Thrall MJ
Arch Pathol Lab Med; 2015 Nov; 139(11):1431-6. PubMed ID: 25951104
[TBL] [Abstract][Full Text] [Related]
34. Impact of an educational tool on young women's knowledge of cervical cancer screening recommendations.
Thiel de Bocanegra H; Dehlendorf C; Kuppermann M; Vangala SS; Moscicki AB
Cancer Causes Control; 2022 Jun; 33(6):813-821. PubMed ID: 35312891
[TBL] [Abstract][Full Text] [Related]
35. Understanding Transgender Men's Experiences with and Preferences for Cervical Cancer Screening: A Rapid Assessment Survey.
Seay J; Ranck A; Weiss R; Salgado C; Fein L; Kobetz E
LGBT Health; 2017 Aug; 4(4):304-309. PubMed ID: 28422558
[TBL] [Abstract][Full Text] [Related]
36. A tailored within-community specimen collection strategy increased uptake of cervical cancer screening in a cross-sectional study in Ghana.
Awua AK; Wiredu EK; Afari EA; Tijani AS; Djanmah G; Adanu RMK
BMC Public Health; 2017 Aug; 18(1):80. PubMed ID: 28764756
[TBL] [Abstract][Full Text] [Related]
37. Prevalence and determinants of cervical cancer screening with a combination of cytology and human papillomavirus testing.
Fokom Domgue J; Cunningham SA; Yu RK; Shete S
Ann Epidemiol; 2019 Aug; 36():40-47. PubMed ID: 31320153
[TBL] [Abstract][Full Text] [Related]
38. Patient concerns about human papillomavirus testing and 5-year intervals in routine cervical cancer screening.
Silver MI; Rositch AF; Burke AE; Chang K; Viscidi R; Gravitt PE
Obstet Gynecol; 2015 Feb; 125(2):317-329. PubMed ID: 25568994
[TBL] [Abstract][Full Text] [Related]
39. Human papilloma virus testing knowledge and attitudes among women attending colposcopy clinic with ASCUS/LGSIL pap smears.
Le T; Hicks W; Menard C; Boyd D; Hewson T; Hopkins L; Kee Fung MF
J Obstet Gynaecol Can; 2004 Sep; 26(9):788-92. PubMed ID: 15361273
[TBL] [Abstract][Full Text] [Related]
40. Rationale and design of the HOME trial: A pragmatic randomized controlled trial of home-based human papillomavirus (HPV) self-sampling for increasing cervical cancer screening uptake and effectiveness in a U.S. healthcare system.
Winer RL; Tiro JA; Miglioretti DL; Thayer C; Beatty T; Lin J; Gao H; Kimbel K; Buist DSM
Contemp Clin Trials; 2018 Jan; 64():77-87. PubMed ID: 29113956
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
